FDA Inspection
Neutraderm Inc.Neutraderm Inc. – FDA Inspection, Dec 9, 2022
Record Details
This FDA Inspection record concerns Neutraderm Inc., with an inspection on December 9, 2022, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Neutraderm Inc.
- Inspection Date
- December 9, 2022
- Product Type
- Drugs
View Company Profile
ID · c8c104d8-8cb7-4eca-84ab-dcf7992033c7
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1192551
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
6- 21 CFR 211.67(a)Cleaning / Sanitizing / Maintenance
- 21 CFR 211.67(b)(3)Cleaning SOPs/instructions
- 21 CFR 211.22(c)Approve or reject procedures or specs
- 21 CFR 211.111Establishment of time limitations
- 21 CFR 211.160(b)(4)Written calibration procedures
- 21 CFR 211.182Written records kept in individual logs
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Neutraderm Inc.
7| Date | Classification | Office | Project area |
|---|---|---|---|
| June 15, 2026 | Not classified | Los Angeles District Office | |
| September 14, 2018 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 22, 2016 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 26, 2013 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| December 2, 2011 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Neutraderm Inc.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.